Samer Gawrieh
Overview
Explore the profile of Samer Gawrieh including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
104
Citations
2155
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Nguyen C, Su J, Li Y, Healey R, Jiang S, Li J, et al.
Hepatol Commun
. 2025 Jan;
9(2).
PMID: 39878651
Background: Alcohol-associated hepatitis (AH) leads to high rates of mortality and health care costs. Understanding the immediate costs after an AH diagnosis and identifying key cost factors is crucial for...
2.
Lin K, Vilar-Gomez E, Corey K, Connelly M, Gupta S, Lake J, et al.
Lipids Health Dis
. 2024 Oct;
23(1):339.
PMID: 39420356
Background: Metabolic dysfunction associated steatotic liver disease (MASLD) is associated with increased cardiovascular disease (CVD) risk in persons with HIV (PWH). The lipidomic and metabolomic alterations contributing to this risk...
3.
Vilar-Gomez E, Gawrieh S, Vuppalanchi R, Kettler C, Pike F, Samala N, et al.
J Hepatol
. 2024 Oct;
PMID: 39389267
Background & Aims: Little is known about the interplay between patatin-like phospholipase domain-containing protein 3 (PNPLA3 rs738409 C>G), environmental factors, and the risk of liver-related death (LRD). Methods: A total...
4.
Honarvar M, Lobo J, Schneider C, Wolfe N, Gawrieh S, Loomba R, et al.
Ultrasound Med Biol
. 2024 Sep;
50(12):1812-1820.
PMID: 39244483
Objective: As metabolic dysfunction-associated steatotic liver disease (MASLD) becomes more prevalent worldwide, it is imperative to create more accurate technologies that make it easy to assess the liver in a...
5.
Allende D, Cummings O, Sternberg A, Behling C, Carpenter D, Gill R, et al.
Aliment Pharmacol Ther
. 2024 Sep;
60(10):1351-1360.
PMID: 39238213
Background: Metabolic dysfunction-associated steatotic liver disease (MASLD) is common in people with HIV (PWH). The morphological spectrum of MASLD compared to matched controls and of the correlation between the NAFLD...
6.
Patidar K, Tu W, Cotter T, Simonetto D, Asgharpour A, Jan M, et al.
Hepatology
. 2024 Jul;
PMID: 39028887
Background And Aims: In a recent trial, patients with severe alcohol-associated hepatitis treated with anakinra plus zinc (A+Z) had lower survival and higher acute kidney injury (AKI) rates versus prednisone...
7.
Lin K, Amigo N, Ortiz P, Alonso C, Smolensky A, Parmar D, et al.
Clin Investig Arterioscler
. 2024 Jun;
37(1):100723.
PMID: 38945785
Background And Aims: Comprehensive assessment of pharmacotherapy effects on atherogenic parameters (AP) that influence the risk of cardiovascular disease (CVD) is challenging due to interactions among a large number of...
8.
Tu W, Liangpunsakul S, Nguyen C, Healey R, Li Y, Radaeva S, et al.
Alcohol
. 2024 Jun;
120:143-150.
PMID: 38908609
Background/aims: Alcohol-associated hepatitis (AH) mortality and risk factors have not been carefully studied in real-world settings. We examined the rate, temporal trend, and risk factors of mortality in AH. Methods:...
9.
Gawrieh S, Vilar-Gomez E, Wilson L, Pike F, Kleiner D, Neuschwander-Tetri B, et al.
J Hepatol
. 2024 May;
81(4):600-608.
PMID: 38762169
Background & Aims: The clinical significance of change in liver stiffness measurement (LSM) by vibration-controlled transient elastography (VCTE) in patients with non-alcoholic fatty liver disease (NAFLD) is not well-understood. We...
10.
Schwantes-An T, Whitfield J, Aithal G, Atkinson S, Bataller R, Botwin G, et al.
Hepatol Commun
. 2024 May;
8(6).
PMID: 38727677
Background: Polygenic Risk Scores (PRS) based on results from genome-wide association studies offer the prospect of risk stratification for many common and complex diseases. We developed a PRS for alcohol-associated...